Correlation Between Intech Biopharm and Swancor Holding

Can any of the company-specific risk be diversified away by investing in both Intech Biopharm and Swancor Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intech Biopharm and Swancor Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Intech Biopharm and Swancor Holding Co, you can compare the effects of market volatilities on Intech Biopharm and Swancor Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intech Biopharm with a short position of Swancor Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intech Biopharm and Swancor Holding.

Diversification Opportunities for Intech Biopharm and Swancor Holding

0.7

Correlation Coefficient

Intech Biopharm  Swancor Holding

Poor diversification

The 3 months correlation between Intech and Swancor is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Intech Biopharm and Swancor Holding Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Swancor Holding and Intech Biopharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intech Biopharm are associated (or correlated) with Swancor Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Swancor Holding has no effect on the direction of Intech Biopharm i.e., Intech Biopharm and Swancor Holding go up and down completely randomly.

Pair Corralation between Intech Biopharm and Swancor Holding

Assuming the 90 days trading horizon Intech Biopharm is expected to under-perform the Swancor Holding. But the stock apears to be less risky and, when comparing its historical volatility, Intech Biopharm is 1.07 times less risky than Swancor Holding. The stock trades about -0.19 of its potential returns per unit of risk. The Swancor Holding Co is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest  8,880  in Swancor Holding Co on December 30, 2024 and sell it today you would lose (960.00) from holding Swancor Holding Co or give up 10.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Intech Biopharm  vs.  Swancor Holding Co

Intech Biopharm

Risk-Adjusted Performance

Very Weak

Over the last 90 days Intech Biopharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Swancor Holding

Risk-Adjusted Performance

Very Weak

Over the last 90 days Swancor Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Intech Biopharm and Swancor Holding

The main advantage of trading using opposite Intech Biopharm and Swancor Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intech Biopharm position performs unexpectedly, Swancor Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Swancor Holding will offset losses from the drop in Swancor Holding's long position.

The idea behind Intech Biopharm and Swancor Holding Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.